COMMUNIQUÉS West-GlobeNewswire

Canntab & FSD Pharma Make Cannabis More Palatable for Doctors -- CFN Media

21/12/2018 - 15:00

SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Planet 13 Revenue Soars 63% as Las Vegas Takes Off -- CFN Media

21/12/2018 - 15:00

SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Aleafia-Emblem Merger Creates Canada’s Largest Network of Clinics -- CFN Media

21/12/2018 - 15:00

SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Gabriella's Kitchen Adding Seasoned Executives To The Board -- CFN Media

21/12/2018 - 15:00

SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Aptevo Therapeutics Announces Up To $35 Million Common Stock Purchase Agreement With Lincoln Park Capital

21/12/2018 - 15:00

Provides Opportunistic Capital of up to $35 Million to Aptevo During the 36-month Term of the Agreement SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused [...]

Editas Medicine Announces Transition of Chief Financial Officer

21/12/2018 - 15:00

CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that its Chief Financial Officer, Andrew Hack, M.D., Ph.D., will be stepping [...]

Novartis successfully completes acquisition of Endocyte

21/12/2018 - 14:54

Adds 177 Lu-PSMA-617, a potential first-in-class radioligand therapy in Phase III development for metastatic castration-resistant prostate cancer (mCRPC) Strengthens leadership in nuclear medicine and radioligand [...]

Align Technology Receives Multiple Product Awards for iTero Element 2 and iTero Element Flex Scanners

21/12/2018 - 14:30

SAN JOSE, Calif., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that the iTero Element 2 and iTero Element Flex scanners have been honored with multiple product awards from two [...]

Microbix Reports Results for Fiscal 2018

21/12/2018 - 14:30

Full-Year Sales Growth of 23%, Progress Toward Sustained Profitability TORONTO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, [...]

TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma

21/12/2018 - 14:10

SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]

Novo Nordisk A/S: Share repurchase programme

21/12/2018 - 14:05

Bagsværd, Denmark, 21 December 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE

21/12/2018 - 14:04

RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE Milan, 21 December 2018 – Recordati announces the signing of an agreement for the acquisition of 100% of the share capital of Tonipharm S.A.S., a French company based in [...]

Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference

21/12/2018 - 14:00

BOSTON, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 37 th Annual J.P. Morgan Healthcare [...]

CTD Holdings Closes $2.0 Million Private Placement

21/12/2018 - 14:00

ALACHUA, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]

Entry into a Material Definitive Agreement

21/12/2018 - 14:00

MIAMI, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ) (the “Company”) a personalized healthcare services and technology company, announced today that, through its wholly-owned subsidiary, [...]

Project HOPE Deploys Medical Team to Colombian Border Towns to Ease Suffering of Venezuelans

21/12/2018 - 14:00

Millwood, VA, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Project HOPE says it is scaling up its medical response in the border regions in Colombia as thousands of displaced Venezuelans continue to pour across the border each day [...]

Abattis Provides Marketing and Operational Updates

21/12/2018 - 14:00

VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce the launch of its new website and provide an [...]

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

21/12/2018 - 14:00

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat Licensing rights are worldwide excluding US, Canada, Japan and South America Lugano, Switzerland and Florence, Italy, December 21, 2018: [...]

Nemaura Announces Completion of Key Stages of Technical File Review for SugarBEAT® CE Mark Approval

21/12/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]